Search
for
Sort by
Research 61–90 of 1000+
- Prognostic factors that affect the response to topical treatment in patchy alopecia areata
- Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Alopecia Areata in an Adolescent With Inflammatory Bowel Disease
- A clinical study on alopecia areata
- Alopecia Areata and Alopecia Areata Incognita
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Dermoscopic Assessment of Nail Alterations in Egyptian Patients with Alopecia Areata
- Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata
- Clinical and Trichoscopic Study of Tinea Capitis versus Alopecia Areata in Pediatric Patients
- Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata
- Alopecia Areata Ophiasic with Ciliary Madarosis in A Pediatric Patient: Case Report
- ALOPECIA AREATA
- Camouflage technique for alopecia areata: What is a patient to do?
- Alopecia Areata
- Clinical significance of dermoscopy in alopecia areata: analysis of 300 cases
- Guidelines for the management of alopecia areata
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Trichoscopy of alopecia areata: An update
- Alopecia Areata Update
- Alopecia areata: An update
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- The role of lymphocytes in the development and treatment of alopecia areata
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Bimatoprost in the treatment of eyelash universalis alopecia areata
- Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse